About Us
Technology & Pipeline
Corporate Governance
Investors
Media
Contact

About Us
Technology & Pipeline
Corporate Governance
Investors
Media
Contact

Vacant positions

Please visit our Swedish site for a list of all vacant positions.

Spontaneous applications can be sent to jobb@oasmia.com.

About Us

About Us
Technology & Pipeline
Corporate Governance
Investors
Media
Contact

Oasmia Pharmaceutical AB is a specialty pharmaceutical company focused on thedevelopment of new therapeutic options for patients suffering from hard-to-treatcancers. It has an emerging pipeline of clinical-stage assets targeting late-stagecancers. Apealea® (paclitaxel micellar) is being made available to ovarian cancerpatients through a partnership with Elevar Therapeutics, Inc. Development programsinclude Cantrixil, in clinical development for late-stage ovarian cancer, and docetaxelmicellar, in development for advanced prostate cancer. Oasmia has proprietary drugdelivery technology designed to improve solubility, efficacy and safety.

The Share

Follow the share

Personal data
Cookies

OAS-MA-P-001-SEP2020

Oasmia Pharmaceutical AB
Vallongatan 1
752 28 Uppsala

Tel +46 18 50 54 40
Fax +46 18 51 08 73
info@oasmia.com